ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CSTL vs TRUP // EV/EBITDA & P/E VALUATION

Castle Biosciences Inc. (NASDAQ) VS. Trupanion Inc. (NASDAQ) • 15-METRIC TALLY: CSTL 2 — TRUP 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CSTL VS. TRUP) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CSTL TRUP SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 79.40% 16.10% +63.30 CSTL /gross-margins <GO>
Return on Invested Capital (ROIC) -9.30% 3.10% -12.40 TRUP /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 49.8x — TIE /valuation <GO>
Free Cash Flow Yield 2.41% 5.69% -3.28 TRUP /fcf-yield <GO>
Operating Margin -12.40% 1.00% -13.40 TRUP /operating-margins <GO>
Net Profit Margin -7.00% 1.40% -8.40 TRUP /net-margins <GO>
Revenue Growth (YoY) 3.70% 11.90% -8.20 TRUP /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 6.97 3.17 +3.80 CSTL /balance-sheet <GO>
Piotroski F-Score Quality 6/9 8/9 -2.00 TRUP /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 60.9 67.4 -6.54 TRUP /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 63.4x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.18B $1.32B -$148.1M TRUP /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CSTL REV TRUP REV CSTL GROSS % TRUP GROSS % CSTL FCF TRUP FCF
FY 2025 $344.2M $1.44B 79.4% 16.1% $28.3M $75.4M
FY 2024 $332.1M $1.29B 81.9% 13.9% $36.5M $38.6M
FY 2023 $219.8M $1.11B — — -$5.6M $18.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CSTL // BETA —
TRUP // BETA —